Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("CLEMENTS, Philip J")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 42

  • Page / 2
Export

Selection :

  • and

Infliximab may be effective in the treatment of steroid-resistant eosinophilic fasciitis: report of three casesKHANNA, Dinesh; AGRAWAL, Harsh; CLEMENTS, Philip J et al.Rheumatology (Oxford. Print). 2010, Vol 49, Num 6, pp 1184-1188, issn 1462-0324, 5 p.Article

Predicting Treatment Outcomes and Responder Subsets in Scleroderma-Related Interstitial Lung DiseaseROTH, Michael D; TSENG, Chi-Hong; ELASHOFF, Robert M et al.Arthritis and rheumatism. 2011, Vol 63, Num 9, pp 2797-2808, issn 0004-3591, 12 p.Article

Sensitivity to change of the modified Rodnan skin score in diffuse systemic sclerosis―assessment of individual body sites in two large randomized controlled trialsKALDAS, Marian; KHANNA, Puja P; FURST, Daniel E et al.Rheumatology (Oxford. Print). 2009, Vol 48, Num 9, pp 1143-1146, issn 1462-0324, 4 p.Article

Vitamin D, Parathyroid Hormone, and Acroosteolysis in Systemic SclerosisBRAUN-MOSCOVICI, Yolanda; FURST, Daniel E; MARKOVITS, Doron et al.Journal of rheumatology. 2008, Vol 35, Num 11, pp 2201-2205, issn 0315-162X, 5 p.Article

High-dose versus low-dose d-penicillamine in early diffuse systemic sclerosis trial: Lessons learnedCLEMENTS, Philip J; SEIBOLD, James R; STEEN, Virginia et al.Seminars in arthritis and rheumatism. 2004, Vol 33, Num 4, pp 249-263, issn 0049-0172, 15 p.Article

Update on disease-modifying antirheumatic drugs in the treatment of systemic sclerosisLIN, Antony T. H; CLEMENTS, Philip J; FURST, Daniel E et al.Rheumatic diseases clinics of North America. 2003, Vol 29, Num 2, pp viii-ix, issn 0889-857X, 30 p.Article

Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosisBODUKAM, Vijay; HAYS, Ron D; MARANIAN, Paul et al.Rheumatology (Oxford. Print). 2011, Vol 50, Num 2, pp 330-334, issn 1462-0324, 5 p.Article

Reliability and Validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract InstrumentKHANNA, Dinesh; HAYS, Ron D; FURST, Daniel E et al.Arthritis care and research. 2009, Vol 61, Num 9, pp 1257-1263, issn 0893-7524, 7 p.Article

Minimally important differences in the Mahler's Transition Dyspnoea Index in a large randomized controlled trial—results from the Scleroderma Lung StudyKHANNA, Dinesh; TSENG, Chi-Hong; FURST, Daniel E et al.Rheumatology (Oxford. Print). 2009, Vol 48, Num 12, pp 1537-1540, issn 1462-0324, 4 p.Article

Lymphomatoid granulomatosis : A rare mimicker of vasculitisWU, Sherry M; MIN, Yoon; OSTRZEGA, Nora et al.Journal of rheumatology. 2005, Vol 32, Num 11, pp 2242-2245, issn 0315-162X, 4 p.Article

Regional differences in bronchoalveolar lavage and thoracic high-resolution computed tomography results in dyspneic patients with systemic sclerosisCLEMENTS, Philip J; GOLDIN, Jonathan G; KLEERUP, Eric C et al.Arthritis and rheumatism. 2004, Vol 50, Num 6, pp 1909-1917, issn 0004-3591, 9 p.Article

The Disability Index of the health assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trialCLEMENTS, Philip J; WENG KEE WONG; MEDSGER, Thomas A et al.Arthritis and rheumatism. 2001, Vol 44, Num 3, pp 653-661, issn 0004-3591Article

Articular involvement in systemic sclerosisAVOUAC, Jérôme; CLEMENTS, Philip J; KHANNA, Dinesh et al.Rheumatology (Oxford. Print). 2012, Vol 51, Num 8, pp 1347-1356, issn 1462-0324, 10 p.Article

Adverse Events during the Scleroderma Lung StudyFURST, Daniel E; TSENG, Chi-Hong; CLEMENTS, Philip J et al.The American journal of medicine. 2011, Vol 124, Num 5, pp 459-467, issn 0002-9343, 9 p.Article

Clinical Course of Lung Physiology in Patients With Scleroderma and Interstitial Lung Disease: Analysis of the Scleroderma Lung Study Placebo GroupKHANNA, Dinesh; TSENG, Chi-Hong; SAGGAR, Rajeev et al.Arthritis and rheumatism. 2011, Vol 63, Num 10, pp 3078-3085, issn 0004-3591, 8 p.Article

Cyclophosphamide versus placebo in scleroderma lung diseaseTASHKIN, Donald P; ELASHOFF, Robert; SEIBOLD, James R et al.The New England journal of medicine. 2006, Vol 354, Num 25, pp 2655-2666, issn 0028-4793, 12 p.Article

Current status of outcome measure development for clinical trials in Systemic sclerosis. Report from OMERACT 6MERKEL, Peter A; CLEMENTS, Philip J; REVEILLE, John D et al.Journal of rheumatology. 2003, Vol 30, Num 7, pp 1630-1647, issn 0315-162X, 18 p.Conference Paper

New onset systemic lupus erythematosus with pheochromocytomaLIN, Antony T. H; YOON MIN; CLEMENTS, Philip J et al.Journal of rheumatology. 2002, Vol 29, Num 6, pp 1334-1337, issn 0315-162XArticle

Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: High-dose versus low-dose penicillamine trialCLEMENTS, Philip J; HURWITZ, Eric L; MEDSGER, Thomas A et al.Arthritis and rheumatism. 2000, Vol 43, Num 11, pp 2445-2454, issn 0004-3591Article

Arthritis in Systemic Sclerosis: Systematic Review of the Literature and Suggestions for the Performance of Future Clinical Trials in Systemic Sclerosis ArthritisCLEMENTS, Philip J; ALLANORE, Yannick; KHANNA, Dinesh et al.Seminars in arthritis and rheumatism. 2012, Vol 41, Num 6, pp 801-814, issn 0049-0172, 14 p.Article

Work Productivity in Scleroderma: Analysis From the University of California, Los Angeles Scleroderma Quality of Life StudySINGH, Manjit K; CLEMENTS, Philip J; FURST, Daniel E et al.Arthritis care and research. 2012, Vol 64, Num 2, pp 176-183, issn 0893-7524, 8 p.Article

Gender and ethnicity differences in patients with diffuse systemic sclerosis—analysis from three large randomized clinical trialsNASHID, Mahsa; KHANNA, Puja P; KHANNA, Dinesh et al.Rheumatology (Oxford. Print). 2011, Vol 50, Num 2, pp 335-342, issn 1462-0324, 8 p.Article

Minimally Important Differences of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract InstrumentKHANNA, Dinesh; FURST, Daniel E; MARANIAN, Paul et al.Journal of rheumatology. 2011, Vol 38, Num 9, pp 1920-1924, issn 0315-162X, 5 p.Article

Development of a preliminary scleroderma gastrointestinal tract 1.0 quality of life instrumentKHANNA, Dinesh; HAYS, Ron D; PARK, Grace S et al.Arthritis care and research. 2007, Vol 57, Num 7, pp 1280-1286, issn 0893-7524, 7 p.Article

Relationships of positive and Negative Affect to Coping and functional outcomes in systemic sclerosisHANSDOTTIR, Ingunn; MALCARNE, Vanessa L; FURST, Daniel E et al.Cognitive therapy and research. 2004, Vol 28, Num 5, pp 593-610, issn 0147-5916, 18 p.Article

  • Page / 2